Trevenaincis A Biopharmaceutical Company Focused On Developing And Commercializing Innovative Medicines For Central Nervous Systemcnsdisorders And Pain Managementheadquartered In Chesterbrookpennsylvaniatrevena Aims To Deliver Effective Therapeutic Solutions That Address Critical Patient Needsthe Company Specializes In Medications Targeting G Protein Coupled Receptorsgpcrs Which Play A Vital Role In Various Physiological Processes Trevena S Product Pipeline Includes Olinvykoliceridine An Intravenous Medication For Managing Moderate To Severe Acute Painand Several Other Promising Candidates Such As Trv250 For Acute Migrainetrv734 For Opioid Use Disorderand Trv045 For Neuropathic Painthe Company Is Actively Engaged In Research And Developmentwith Ongoing Clinical Trials To Advance Its Innovative Therapiestrevena Is Publicly Traded On Nasdaq Under The Ticker Symbol Trvn
No conferences found for this company.
| Company Name | Trevena Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
